Current evidence seems to indicate that due to individual variability in response to clopidogrel, as many as 30% of patients on maintenance clopidogrel (75 mg/day) may show elevated platelet ...

NEW ORLEANS, LA—The debate over the use of pharmacogenomic- or pharmacodynamic-tailored antiplatelet therapy continues to be a subject of interest at ACC.11, the American College of Cardiology’s 60 th ...

Rochester, MN - Many cardiologists are switching to a 600-mg loading dose of clopidogrel pre-PCI, as this dose achieves maximal inhibition of platelets in just two hours, which shortens waiting time ...

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Clopidogrel Tablets USP 75mg, which is being launched. Clopidogrel Tablets USP ...

Clopidogrel (Clopicard 75mg) is an anti-platelet agent, that is, a drug that inhibits the ability of platelets to clump together as part of a blood clot. Clopidogrel (Clopicard 75mg) is prescribed ...

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.

Golden State Medical Supply, Inc. has voluntarily recalled 1 lot of Clopidogrel 75mg Tablets and 1 lot of Atenolol 25mg Tablets due to a report stating that a bottle containing Clopidogrel 75mg ...

Diminished antiplatelet effect in patients with two loss-of-function alleles of the CYP2C19 gene. Increased risk of bleeding. Premature discontinuation increases risk of cardiovascular events; if ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A reduction of infarct size and improvement of ...

After receiving a report that the label was wrong on a medication, Golden State Medical Supply has recalled one lot of clopidogrel and atenolol. According to an announcement with the U.S. Food and ...